nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—CYP2C9—brain cancer	0.433	1	CbGaD
Lovastatin—UGT1A1—Etoposide—brain cancer	0.0557	0.176	CbGbCtD
Lovastatin—CYP2D6—Lomustine—brain cancer	0.0431	0.136	CbGbCtD
Lovastatin—ABCC2—Carboplatin—brain cancer	0.0404	0.128	CbGbCtD
Lovastatin—ABCC2—Etoposide—brain cancer	0.0339	0.107	CbGbCtD
Lovastatin—CYP2D6—Hydroxyurea—brain cancer	0.0327	0.103	CbGbCtD
Lovastatin—CYP3A4—Temozolomide—brain cancer	0.0322	0.102	CbGbCtD
Lovastatin—CYP3A4—Lomustine—brain cancer	0.0274	0.0866	CbGbCtD
Lovastatin—CYP3A5—Etoposide—brain cancer	0.017	0.0537	CbGbCtD
Lovastatin—CYP2C8—Etoposide—brain cancer	0.0163	0.0516	CbGbCtD
Lovastatin—ABCB1—Etoposide—brain cancer	0.0111	0.0349	CbGbCtD
Lovastatin—Dermatomyositis—Hydroxyurea—brain cancer	0.00846	0.0893	CcSEcCtD
Lovastatin—CYP3A4—Etoposide—brain cancer	0.00662	0.0209	CbGbCtD
Lovastatin—ITGAL—endothelium—brain cancer	0.00428	0.0906	CbGeAlD
Lovastatin—ITGAL—blood vessel—brain cancer	0.00395	0.0835	CbGeAlD
Lovastatin—HDAC2—telencephalic ventricle—brain cancer	0.00319	0.0674	CbGeAlD
Lovastatin—Lupus erythematosus—Hydroxyurea—brain cancer	0.00238	0.0252	CcSEcCtD
Lovastatin—HDAC2—Teniposide—Etoposide—brain cancer	0.00206	1	CbGdCrCtD
Lovastatin—Simvastatin—CYP2C9—brain cancer	0.00204	0.505	CrCbGaD
Lovastatin—Pravastatin—CYP2C9—brain cancer	0.002	0.495	CrCbGaD
Lovastatin—VIIth nerve paralysis—Carmustine—brain cancer	0.00175	0.0185	CcSEcCtD
Lovastatin—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.0016	0.0169	CcSEcCtD
Lovastatin—PON3—pituitary gland—brain cancer	0.00153	0.0323	CbGeAlD
Lovastatin—HDAC2—hindbrain—brain cancer	0.0015	0.0318	CbGeAlD
Lovastatin—ITGAL—medulla oblongata—brain cancer	0.0015	0.0318	CbGeAlD
Lovastatin—ITGAL—midbrain—brain cancer	0.00137	0.0291	CbGeAlD
Lovastatin—ITGAL—spinal cord—brain cancer	0.00134	0.0284	CbGeAlD
Lovastatin—ITGAL—endocrine gland—brain cancer	0.00121	0.0256	CbGeAlD
Lovastatin—PON3—endocrine gland—brain cancer	0.00118	0.0251	CbGeAlD
Lovastatin—Transaminases increased—Carmustine—brain cancer	0.00118	0.0125	CcSEcCtD
Lovastatin—ITGAL—cerebellum—brain cancer	0.00106	0.0225	CbGeAlD
Lovastatin—UGT1A3—endocrine gland—brain cancer	0.00103	0.0217	CbGeAlD
Lovastatin—Gynaecomastia—Procarbazine—brain cancer	0.00103	0.0108	CcSEcCtD
Lovastatin—Tenderness—Hydroxyurea—brain cancer	0.00102	0.0107	CcSEcCtD
Lovastatin—Myopathy—Temozolomide—brain cancer	0.000988	0.0104	CcSEcCtD
Lovastatin—Hepatic function abnormal—Procarbazine—brain cancer	0.000952	0.0101	CcSEcCtD
Lovastatin—Photosensitivity—Procarbazine—brain cancer	0.000948	0.01	CcSEcCtD
Lovastatin—Vascular purpura—Procarbazine—brain cancer	0.00093	0.00983	CcSEcCtD
Lovastatin—Haemolytic anaemia—Procarbazine—brain cancer	0.000922	0.00974	CcSEcCtD
Lovastatin—Memory impairment—Temozolomide—brain cancer	0.000883	0.00933	CcSEcCtD
Lovastatin—ITGAL—brain—brain cancer	0.000864	0.0183	CbGeAlD
Lovastatin—Purpura—Procarbazine—brain cancer	0.000863	0.00912	CcSEcCtD
Lovastatin—HDAC2—brainstem—brain cancer	0.000862	0.0182	CbGeAlD
Lovastatin—PON3—brain—brain cancer	0.000847	0.0179	CbGeAlD
Lovastatin—Accidental injury—Carmustine—brain cancer	0.00081	0.00856	CcSEcCtD
Lovastatin—Alopecia—Lomustine—brain cancer	0.000801	0.00846	CcSEcCtD
Lovastatin—HDAC2—telencephalon—brain cancer	0.000765	0.0162	CbGeAlD
Lovastatin—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000749	0.00792	CcSEcCtD
Lovastatin—Infection—Carboplatin—brain cancer	0.000731	0.00773	CcSEcCtD
Lovastatin—Hepatic failure—Hydroxyurea—brain cancer	0.000717	0.00757	CcSEcCtD
Lovastatin—Eosinophilia—Procarbazine—brain cancer	0.000712	0.00752	CcSEcCtD
Lovastatin—Leukopenia—Lomustine—brain cancer	0.000706	0.00746	CcSEcCtD
Lovastatin—Pancreatitis—Procarbazine—brain cancer	0.000705	0.00745	CcSEcCtD
Lovastatin—Musculoskeletal pain—Temozolomide—brain cancer	0.000701	0.00741	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Temozolomide—brain cancer	0.000693	0.00732	CcSEcCtD
Lovastatin—HMGCR—telencephalon—brain cancer	0.00069	0.0146	CbGeAlD
Lovastatin—Photosensitivity reaction—Procarbazine—brain cancer	0.000656	0.00693	CcSEcCtD
Lovastatin—Gynaecomastia—Carmustine—brain cancer	0.000642	0.00678	CcSEcCtD
Lovastatin—Infection—Lomustine—brain cancer	0.00064	0.00676	CcSEcCtD
Lovastatin—HDAC2—gonad—brain cancer	0.000638	0.0135	CbGeAlD
Lovastatin—Thrombocytopenia—Lomustine—brain cancer	0.000631	0.00666	CcSEcCtD
Lovastatin—Pain—Carboplatin—brain cancer	0.00063	0.00665	CcSEcCtD
Lovastatin—Neuropathy peripheral—Procarbazine—brain cancer	0.000628	0.00664	CcSEcCtD
Lovastatin—HDAC2—pituitary gland—brain cancer	0.000623	0.0132	CbGeAlD
Lovastatin—Anorexia—Lomustine—brain cancer	0.000614	0.00649	CcSEcCtD
Lovastatin—CYP3A7—endocrine gland—brain cancer	0.000608	0.0129	CbGeAlD
Lovastatin—HDAC2—medulla oblongata—brain cancer	0.000601	0.0127	CbGeAlD
Lovastatin—UGT2B7—endocrine gland—brain cancer	0.00059	0.0125	CbGeAlD
Lovastatin—Body temperature increased—Carboplatin—brain cancer	0.000582	0.00615	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000578	0.00611	CcSEcCtD
Lovastatin—HMGCR—gonad—brain cancer	0.000576	0.0122	CbGeAlD
Lovastatin—Injury—Carmustine—brain cancer	0.000566	0.00598	CcSEcCtD
Lovastatin—Vascular purpura—Temozolomide—brain cancer	0.000562	0.00594	CcSEcCtD
Lovastatin—HMGCR—pituitary gland—brain cancer	0.000562	0.0119	CbGeAlD
Lovastatin—Decreased appetite—Lomustine—brain cancer	0.00056	0.00592	CcSEcCtD
Lovastatin—Hepatic failure—Temozolomide—brain cancer	0.00056	0.00591	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Etoposide—brain cancer	0.000555	0.00586	CcSEcCtD
Lovastatin—Amnesia—Carmustine—brain cancer	0.000554	0.00585	CcSEcCtD
Lovastatin—HDAC2—midbrain—brain cancer	0.000549	0.0116	CbGeAlD
Lovastatin—Pancreatitis—Hydroxyurea—brain cancer	0.000546	0.00576	CcSEcCtD
Lovastatin—HMGCR—medulla oblongata—brain cancer	0.000542	0.0115	CbGeAlD
Lovastatin—SLCO1A2—telencephalon—brain cancer	0.000538	0.0114	CbGeAlD
Lovastatin—Amnesia—Temozolomide—brain cancer	0.000535	0.00566	CcSEcCtD
Lovastatin—Flushing—Procarbazine—brain cancer	0.000534	0.00564	CcSEcCtD
Lovastatin—Purpura—Temozolomide—brain cancer	0.000522	0.00551	CcSEcCtD
Lovastatin—Chills—Procarbazine—brain cancer	0.000516	0.00546	CcSEcCtD
Lovastatin—Body temperature increased—Lomustine—brain cancer	0.000509	0.00538	CcSEcCtD
Lovastatin—Alopecia—Procarbazine—brain cancer	0.000509	0.00537	CcSEcCtD
Lovastatin—UGT1A1—endocrine gland—brain cancer	0.000501	0.0106	CbGeAlD
Lovastatin—HMGCR—midbrain—brain cancer	0.000496	0.0105	CbGeAlD
Lovastatin—CYP2D6—hindbrain—brain cancer	0.000493	0.0104	CbGeAlD
Lovastatin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000486	0.00514	CcSEcCtD
Lovastatin—HMGCR—spinal cord—brain cancer	0.000484	0.0102	CbGeAlD
Lovastatin—HDAC2—endocrine gland—brain cancer	0.000483	0.0102	CbGeAlD
Lovastatin—HDAC2—head—brain cancer	0.000476	0.0101	CbGeAlD
Lovastatin—Tremor—Procarbazine—brain cancer	0.000469	0.00496	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000463	0.00489	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000453	0.00479	CcSEcCtD
Lovastatin—Leukopenia—Procarbazine—brain cancer	0.000449	0.00474	CcSEcCtD
Lovastatin—HMGCR—endocrine gland—brain cancer	0.000435	0.00922	CbGeAlD
Lovastatin—HDAC2—central nervous system—brain cancer	0.000435	0.0092	CbGeAlD
Lovastatin—HMGCR—head—brain cancer	0.00043	0.0091	CbGeAlD
Lovastatin—Myalgia—Procarbazine—brain cancer	0.000427	0.00451	CcSEcCtD
Lovastatin—Arthralgia—Procarbazine—brain cancer	0.000427	0.00451	CcSEcCtD
Lovastatin—Anxiety—Procarbazine—brain cancer	0.000425	0.00449	CcSEcCtD
Lovastatin—HDAC2—cerebellum—brain cancer	0.000425	0.009	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—brain cancer	0.000423	0.00895	CbGeAlD
Lovastatin—Dry mouth—Procarbazine—brain cancer	0.000417	0.00441	CcSEcCtD
Lovastatin—SLCO1B1—endocrine gland—brain cancer	0.000417	0.00883	CbGeAlD
Lovastatin—Confusional state—Procarbazine—brain cancer	0.000412	0.00436	CcSEcCtD
Lovastatin—Vomiting—Lomustine—brain cancer	0.00041	0.00433	CcSEcCtD
Lovastatin—Infection—Procarbazine—brain cancer	0.000406	0.00429	CcSEcCtD
Lovastatin—Erectile dysfunction—Temozolomide—brain cancer	0.0004	0.00423	CcSEcCtD
Lovastatin—Thrombocytopenia—Procarbazine—brain cancer	0.0004	0.00423	CcSEcCtD
Lovastatin—Chills—Hydroxyurea—brain cancer	0.0004	0.00422	CcSEcCtD
Lovastatin—Photosensitivity reaction—Temozolomide—brain cancer	0.000397	0.00419	CcSEcCtD
Lovastatin—Alopecia—Hydroxyurea—brain cancer	0.000394	0.00416	CcSEcCtD
Lovastatin—Neuropathy peripheral—Carmustine—brain cancer	0.000393	0.00415	CcSEcCtD
Lovastatin—HMGCR—central nervous system—brain cancer	0.000392	0.00831	CbGeAlD
Lovastatin—Urinary tract infection—Carmustine—brain cancer	0.00039	0.00412	CcSEcCtD
Lovastatin—Anorexia—Procarbazine—brain cancer	0.00039	0.00412	CcSEcCtD
Lovastatin—SLCO1A2—midbrain—brain cancer	0.000386	0.00818	CbGeAlD
Lovastatin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000384	0.00406	CcSEcCtD
Lovastatin—HMGCR—cerebellum—brain cancer	0.000383	0.00812	CbGeAlD
Lovastatin—Nausea—Lomustine—brain cancer	0.000383	0.00404	CcSEcCtD
Lovastatin—Neuropathy peripheral—Temozolomide—brain cancer	0.00038	0.00401	CcSEcCtD
Lovastatin—SLCO1A2—spinal cord—brain cancer	0.000377	0.00798	CbGeAlD
Lovastatin—Urinary tract infection—Temozolomide—brain cancer	0.000377	0.00398	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000373	0.00394	CcSEcCtD
Lovastatin—ABCB1—blood vessel—brain cancer	0.000372	0.00787	CbGeAlD
Lovastatin—Insomnia—Procarbazine—brain cancer	0.00037	0.00391	CcSEcCtD
Lovastatin—Paraesthesia—Procarbazine—brain cancer	0.000367	0.00388	CcSEcCtD
Lovastatin—Sinusitis—Temozolomide—brain cancer	0.000364	0.00384	CcSEcCtD
Lovastatin—Cramp muscle—Etoposide—brain cancer	0.000362	0.00383	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000362	0.00383	CcSEcCtD
Lovastatin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00036	0.0038	CcSEcCtD
Lovastatin—Decreased appetite—Procarbazine—brain cancer	0.000355	0.00376	CcSEcCtD
Lovastatin—Fatigue—Procarbazine—brain cancer	0.000353	0.00372	CcSEcCtD
Lovastatin—Malaise—Hydroxyurea—brain cancer	0.00035	0.00369	CcSEcCtD
Lovastatin—Pain—Procarbazine—brain cancer	0.00035	0.00369	CcSEcCtD
Lovastatin—Constipation—Procarbazine—brain cancer	0.00035	0.00369	CcSEcCtD
Lovastatin—Hepatitis—Temozolomide—brain cancer	0.000348	0.00368	CcSEcCtD
Lovastatin—Leukopenia—Hydroxyurea—brain cancer	0.000347	0.00367	CcSEcCtD
Lovastatin—HDAC2—brain—brain cancer	0.000345	0.00731	CbGeAlD
Lovastatin—SLCO1A2—endocrine gland—brain cancer	0.000339	0.00719	CbGeAlD
Lovastatin—Feeling abnormal—Procarbazine—brain cancer	0.000337	0.00356	CcSEcCtD
Lovastatin—SLCO1A2—head—brain cancer	0.000335	0.00709	CbGeAlD
Lovastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000334	0.00353	CcSEcCtD
Lovastatin—Flushing—Carmustine—brain cancer	0.000334	0.00353	CcSEcCtD
Lovastatin—Erythema multiforme—Temozolomide—brain cancer	0.000329	0.00348	CcSEcCtD
Lovastatin—Discomfort—Hydroxyurea—brain cancer	0.000326	0.00345	CcSEcCtD
Lovastatin—Urticaria—Procarbazine—brain cancer	0.000325	0.00343	CcSEcCtD
Lovastatin—Body temperature increased—Procarbazine—brain cancer	0.000323	0.00342	CcSEcCtD
Lovastatin—Abdominal pain—Procarbazine—brain cancer	0.000323	0.00342	CcSEcCtD
Lovastatin—Flushing—Temozolomide—brain cancer	0.000323	0.00341	CcSEcCtD
Lovastatin—Alopecia—Carmustine—brain cancer	0.000318	0.00336	CcSEcCtD
Lovastatin—ABCC2—endocrine gland—brain cancer	0.000316	0.00669	CbGeAlD
Lovastatin—Infection—Hydroxyurea—brain cancer	0.000314	0.00332	CcSEcCtD
Lovastatin—Chills—Temozolomide—brain cancer	0.000312	0.0033	CcSEcCtD
Lovastatin—HMGCR—brain—brain cancer	0.000311	0.00659	CbGeAlD
Lovastatin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00031	0.00327	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000308	0.00325	CcSEcCtD
Lovastatin—Alopecia—Temozolomide—brain cancer	0.000308	0.00325	CcSEcCtD
Lovastatin—CYP2C8—pituitary gland—brain cancer	0.000306	0.00648	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—brain cancer	0.000306	0.00647	CbGeAlD
Lovastatin—Neuropathy peripheral—Etoposide—brain cancer	0.000304	0.00321	CcSEcCtD
Lovastatin—Back pain—Carmustine—brain cancer	0.000303	0.0032	CcSEcCtD
Lovastatin—Anorexia—Hydroxyurea—brain cancer	0.000302	0.00319	CcSEcCtD
Lovastatin—Hypersensitivity—Procarbazine—brain cancer	0.000301	0.00318	CcSEcCtD
Lovastatin—SLCO1A2—cerebellum—brain cancer	0.000299	0.00633	CbGeAlD
Lovastatin—Dysgeusia—Temozolomide—brain cancer	0.000297	0.00313	CcSEcCtD
Lovastatin—Vision blurred—Carmustine—brain cancer	0.000295	0.00312	CcSEcCtD
Lovastatin—Tremor—Carmustine—brain cancer	0.000294	0.0031	CcSEcCtD
Lovastatin—Asthenia—Procarbazine—brain cancer	0.000293	0.0031	CcSEcCtD
Lovastatin—Back pain—Temozolomide—brain cancer	0.000293	0.0031	CcSEcCtD
Lovastatin—Pruritus—Procarbazine—brain cancer	0.000289	0.00306	CcSEcCtD
Lovastatin—Vision blurred—Temozolomide—brain cancer	0.000285	0.00302	CcSEcCtD
Lovastatin—Tremor—Temozolomide—brain cancer	0.000284	0.003	CcSEcCtD
Lovastatin—CYP2D6—brainstem—brain cancer	0.000282	0.00598	CbGeAlD
Lovastatin—Dyspnoea—Hydroxyurea—brain cancer	0.000282	0.00298	CcSEcCtD
Lovastatin—Ill-defined disorder—Temozolomide—brain cancer	0.000281	0.00297	CcSEcCtD
Lovastatin—Leukopenia—Carmustine—brain cancer	0.000281	0.00296	CcSEcCtD
Lovastatin—Diarrhoea—Procarbazine—brain cancer	0.00028	0.00296	CcSEcCtD
Lovastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000279	0.00294	CcSEcCtD
Lovastatin—Angioedema—Temozolomide—brain cancer	0.000277	0.00292	CcSEcCtD
Lovastatin—Decreased appetite—Hydroxyurea—brain cancer	0.000275	0.00291	CcSEcCtD
Lovastatin—Malaise—Temozolomide—brain cancer	0.000273	0.00289	CcSEcCtD
Lovastatin—Fatigue—Hydroxyurea—brain cancer	0.000273	0.00288	CcSEcCtD
Lovastatin—Vertigo—Temozolomide—brain cancer	0.000272	0.00288	CcSEcCtD
Lovastatin—CYP2C19—endocrine gland—brain cancer	0.000272	0.00575	CbGeAlD
Lovastatin—Leukopenia—Temozolomide—brain cancer	0.000271	0.00286	CcSEcCtD
Lovastatin—Pain—Hydroxyurea—brain cancer	0.000271	0.00286	CcSEcCtD
Lovastatin—Constipation—Hydroxyurea—brain cancer	0.000271	0.00286	CcSEcCtD
Lovastatin—Dizziness—Procarbazine—brain cancer	0.00027	0.00286	CcSEcCtD
Lovastatin—Myalgia—Carmustine—brain cancer	0.000267	0.00282	CcSEcCtD
Lovastatin—Chest pain—Carmustine—brain cancer	0.000267	0.00282	CcSEcCtD
Lovastatin—Anxiety—Carmustine—brain cancer	0.000266	0.00281	CcSEcCtD
Lovastatin—Erythema multiforme—Etoposide—brain cancer	0.000263	0.00278	CcSEcCtD
Lovastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000261	0.00276	CcSEcCtD
Lovastatin—Vomiting—Procarbazine—brain cancer	0.00026	0.00275	CcSEcCtD
Lovastatin—Flushing—Etoposide—brain cancer	0.000258	0.00273	CcSEcCtD
Lovastatin—Confusional state—Carmustine—brain cancer	0.000258	0.00273	CcSEcCtD
Lovastatin—Arthralgia—Temozolomide—brain cancer	0.000258	0.00272	CcSEcCtD
Lovastatin—Myalgia—Temozolomide—brain cancer	0.000258	0.00272	CcSEcCtD
Lovastatin—Rash—Procarbazine—brain cancer	0.000258	0.00272	CcSEcCtD
Lovastatin—Dermatitis—Procarbazine—brain cancer	0.000258	0.00272	CcSEcCtD
Lovastatin—Anxiety—Temozolomide—brain cancer	0.000257	0.00272	CcSEcCtD
Lovastatin—Headache—Procarbazine—brain cancer	0.000256	0.00271	CcSEcCtD
Lovastatin—Discomfort—Temozolomide—brain cancer	0.000255	0.00269	CcSEcCtD
Lovastatin—Infection—Carmustine—brain cancer	0.000254	0.00269	CcSEcCtD
Lovastatin—Dry mouth—Temozolomide—brain cancer	0.000252	0.00266	CcSEcCtD
Lovastatin—CYP2D6—telencephalon—brain cancer	0.000251	0.00531	CbGeAlD
Lovastatin—Thrombocytopenia—Carmustine—brain cancer	0.00025	0.00265	CcSEcCtD
Lovastatin—Body temperature increased—Hydroxyurea—brain cancer	0.00025	0.00264	CcSEcCtD
Lovastatin—Chills—Etoposide—brain cancer	0.00025	0.00264	CcSEcCtD
Lovastatin—Confusional state—Temozolomide—brain cancer	0.000249	0.00263	CcSEcCtD
Lovastatin—Anaphylactic shock—Temozolomide—brain cancer	0.000247	0.00261	CcSEcCtD
Lovastatin—Alopecia—Etoposide—brain cancer	0.000246	0.0026	CcSEcCtD
Lovastatin—Infection—Temozolomide—brain cancer	0.000246	0.00259	CcSEcCtD
Lovastatin—Anorexia—Carmustine—brain cancer	0.000244	0.00258	CcSEcCtD
Lovastatin—Nausea—Procarbazine—brain cancer	0.000243	0.00257	CcSEcCtD
Lovastatin—SLCO1A2—brain—brain cancer	0.000243	0.00514	CbGeAlD
Lovastatin—Thrombocytopenia—Temozolomide—brain cancer	0.000242	0.00256	CcSEcCtD
Lovastatin—Dysgeusia—Etoposide—brain cancer	0.000237	0.00251	CcSEcCtD
Lovastatin—CYP2C8—endocrine gland—brain cancer	0.000237	0.00502	CbGeAlD
Lovastatin—Anorexia—Temozolomide—brain cancer	0.000236	0.00249	CcSEcCtD
Lovastatin—Back pain—Etoposide—brain cancer	0.000234	0.00248	CcSEcCtD
Lovastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.000233	0.00246	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000233	0.00246	CcSEcCtD
Lovastatin—Muscle spasms—Etoposide—brain cancer	0.000233	0.00246	CcSEcCtD
Lovastatin—Insomnia—Carmustine—brain cancer	0.000231	0.00244	CcSEcCtD
Lovastatin—Paraesthesia—Carmustine—brain cancer	0.00023	0.00243	CcSEcCtD
Lovastatin—Dyspnoea—Carmustine—brain cancer	0.000228	0.00241	CcSEcCtD
Lovastatin—Asthenia—Hydroxyurea—brain cancer	0.000227	0.0024	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000225	0.00238	CcSEcCtD
Lovastatin—Ill-defined disorder—Etoposide—brain cancer	0.000225	0.00238	CcSEcCtD
Lovastatin—Insomnia—Temozolomide—brain cancer	0.000224	0.00236	CcSEcCtD
Lovastatin—Decreased appetite—Carmustine—brain cancer	0.000222	0.00235	CcSEcCtD
Lovastatin—Paraesthesia—Temozolomide—brain cancer	0.000222	0.00235	CcSEcCtD
Lovastatin—Dyspnoea—Temozolomide—brain cancer	0.00022	0.00233	CcSEcCtD
Lovastatin—Pain—Carmustine—brain cancer	0.000219	0.00231	CcSEcCtD
Lovastatin—Constipation—Carmustine—brain cancer	0.000219	0.00231	CcSEcCtD
Lovastatin—Malaise—Etoposide—brain cancer	0.000219	0.00231	CcSEcCtD
Lovastatin—Vertigo—Etoposide—brain cancer	0.000218	0.0023	CcSEcCtD
Lovastatin—Dyspepsia—Temozolomide—brain cancer	0.000218	0.0023	CcSEcCtD
Lovastatin—Leukopenia—Etoposide—brain cancer	0.000217	0.00229	CcSEcCtD
Lovastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000217	0.00229	CcSEcCtD
Lovastatin—Decreased appetite—Temozolomide—brain cancer	0.000215	0.00227	CcSEcCtD
Lovastatin—CYP3A5—endocrine gland—brain cancer	0.000214	0.00453	CbGeAlD
Lovastatin—Fatigue—Temozolomide—brain cancer	0.000213	0.00225	CcSEcCtD
Lovastatin—Constipation—Temozolomide—brain cancer	0.000211	0.00223	CcSEcCtD
Lovastatin—Pain—Temozolomide—brain cancer	0.000211	0.00223	CcSEcCtD
Lovastatin—Feeling abnormal—Carmustine—brain cancer	0.000211	0.00223	CcSEcCtD
Lovastatin—CYP2C9—endocrine gland—brain cancer	0.000211	0.00446	CbGeAlD
Lovastatin—Dizziness—Hydroxyurea—brain cancer	0.000209	0.00221	CcSEcCtD
Lovastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000209	0.00221	CcSEcCtD
Lovastatin—Chest pain—Etoposide—brain cancer	0.000206	0.00218	CcSEcCtD
Lovastatin—Discomfort—Etoposide—brain cancer	0.000204	0.00215	CcSEcCtD
Lovastatin—Feeling abnormal—Temozolomide—brain cancer	0.000204	0.00215	CcSEcCtD
Lovastatin—Body temperature increased—Carmustine—brain cancer	0.000202	0.00214	CcSEcCtD
Lovastatin—Abdominal pain—Carmustine—brain cancer	0.000202	0.00214	CcSEcCtD
Lovastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.000202	0.00214	CcSEcCtD
Lovastatin—Vomiting—Hydroxyurea—brain cancer	0.000201	0.00213	CcSEcCtD
Lovastatin—Rash—Hydroxyurea—brain cancer	0.0002	0.00211	CcSEcCtD
Lovastatin—Confusional state—Etoposide—brain cancer	0.000199	0.00211	CcSEcCtD
Lovastatin—Dermatitis—Hydroxyurea—brain cancer	0.000199	0.00211	CcSEcCtD
Lovastatin—Headache—Hydroxyurea—brain cancer	0.000198	0.00209	CcSEcCtD
Lovastatin—Anaphylactic shock—Etoposide—brain cancer	0.000198	0.00209	CcSEcCtD
Lovastatin—Infection—Etoposide—brain cancer	0.000197	0.00208	CcSEcCtD
Lovastatin—Urticaria—Temozolomide—brain cancer	0.000196	0.00208	CcSEcCtD
Lovastatin—Abdominal pain—Temozolomide—brain cancer	0.000195	0.00206	CcSEcCtD
Lovastatin—Body temperature increased—Temozolomide—brain cancer	0.000195	0.00206	CcSEcCtD
Lovastatin—Thrombocytopenia—Etoposide—brain cancer	0.000194	0.00205	CcSEcCtD
Lovastatin—Anorexia—Etoposide—brain cancer	0.000189	0.00199	CcSEcCtD
Lovastatin—Hypersensitivity—Carmustine—brain cancer	0.000188	0.00199	CcSEcCtD
Lovastatin—Nausea—Hydroxyurea—brain cancer	0.000188	0.00199	CcSEcCtD
Lovastatin—Asthenia—Carmustine—brain cancer	0.000184	0.00194	CcSEcCtD
Lovastatin—Hypersensitivity—Temozolomide—brain cancer	0.000182	0.00192	CcSEcCtD
Lovastatin—ABCB1—telencephalon—brain cancer	0.00018	0.00382	CbGeAlD
Lovastatin—Paraesthesia—Etoposide—brain cancer	0.000178	0.00188	CcSEcCtD
Lovastatin—Asthenia—Temozolomide—brain cancer	0.000177	0.00187	CcSEcCtD
Lovastatin—Dyspnoea—Etoposide—brain cancer	0.000176	0.00186	CcSEcCtD
Lovastatin—Diarrhoea—Carmustine—brain cancer	0.000175	0.00185	CcSEcCtD
Lovastatin—Pruritus—Temozolomide—brain cancer	0.000175	0.00185	CcSEcCtD
Lovastatin—Decreased appetite—Etoposide—brain cancer	0.000172	0.00182	CcSEcCtD
Lovastatin—Fatigue—Etoposide—brain cancer	0.000171	0.0018	CcSEcCtD
Lovastatin—CYP2C8—brain—brain cancer	0.00017	0.00359	CbGeAlD
Lovastatin—Dizziness—Carmustine—brain cancer	0.000169	0.00179	CcSEcCtD
Lovastatin—Pain—Etoposide—brain cancer	0.000169	0.00179	CcSEcCtD
Lovastatin—Constipation—Etoposide—brain cancer	0.000169	0.00179	CcSEcCtD
Lovastatin—Diarrhoea—Temozolomide—brain cancer	0.000169	0.00179	CcSEcCtD
Lovastatin—Dizziness—Temozolomide—brain cancer	0.000163	0.00173	CcSEcCtD
Lovastatin—Feeling abnormal—Etoposide—brain cancer	0.000163	0.00172	CcSEcCtD
Lovastatin—Vomiting—Carmustine—brain cancer	0.000163	0.00172	CcSEcCtD
Lovastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000162	0.00171	CcSEcCtD
Lovastatin—Rash—Carmustine—brain cancer	0.000161	0.0017	CcSEcCtD
Lovastatin—Dermatitis—Carmustine—brain cancer	0.000161	0.0017	CcSEcCtD
Lovastatin—CYP3A4—endocrine gland—brain cancer	0.000161	0.0034	CbGeAlD
Lovastatin—Headache—Carmustine—brain cancer	0.00016	0.00169	CcSEcCtD
Lovastatin—CYP2D6—endocrine gland—brain cancer	0.000158	0.00335	CbGeAlD
Lovastatin—Vomiting—Temozolomide—brain cancer	0.000157	0.00166	CcSEcCtD
Lovastatin—Urticaria—Etoposide—brain cancer	0.000157	0.00166	CcSEcCtD
Lovastatin—Abdominal pain—Etoposide—brain cancer	0.000156	0.00165	CcSEcCtD
Lovastatin—Body temperature increased—Etoposide—brain cancer	0.000156	0.00165	CcSEcCtD
Lovastatin—CYP2D6—head—brain cancer	0.000156	0.0033	CbGeAlD
Lovastatin—Rash—Temozolomide—brain cancer	0.000156	0.00165	CcSEcCtD
Lovastatin—Dermatitis—Temozolomide—brain cancer	0.000156	0.00165	CcSEcCtD
Lovastatin—Headache—Temozolomide—brain cancer	0.000155	0.00164	CcSEcCtD
Lovastatin—Nausea—Carmustine—brain cancer	0.000152	0.00161	CcSEcCtD
Lovastatin—ABCB1—gonad—brain cancer	0.00015	0.00318	CbGeAlD
Lovastatin—Nausea—Temozolomide—brain cancer	0.000147	0.00155	CcSEcCtD
Lovastatin—ABCB1—pituitary gland—brain cancer	0.000147	0.00311	CbGeAlD
Lovastatin—Hypersensitivity—Etoposide—brain cancer	0.000146	0.00154	CcSEcCtD
Lovastatin—CYP3A4—central nervous system—brain cancer	0.000145	0.00306	CbGeAlD
Lovastatin—CYP2D6—central nervous system—brain cancer	0.000142	0.00302	CbGeAlD
Lovastatin—Asthenia—Etoposide—brain cancer	0.000142	0.0015	CcSEcCtD
Lovastatin—ABCB1—medulla oblongata—brain cancer	0.000142	0.003	CbGeAlD
Lovastatin—Pruritus—Etoposide—brain cancer	0.00014	0.00148	CcSEcCtD
Lovastatin—CYP2D6—cerebellum—brain cancer	0.000139	0.00295	CbGeAlD
Lovastatin—Diarrhoea—Etoposide—brain cancer	0.000135	0.00143	CcSEcCtD
Lovastatin—Dizziness—Etoposide—brain cancer	0.000131	0.00138	CcSEcCtD
Lovastatin—ABCB1—midbrain—brain cancer	0.000129	0.00274	CbGeAlD
Lovastatin—ABCB1—spinal cord—brain cancer	0.000126	0.00267	CbGeAlD
Lovastatin—Vomiting—Etoposide—brain cancer	0.000126	0.00133	CcSEcCtD
Lovastatin—Rash—Etoposide—brain cancer	0.000125	0.00132	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—brain cancer	0.000125	0.00132	CcSEcCtD
Lovastatin—Headache—Etoposide—brain cancer	0.000124	0.00131	CcSEcCtD
Lovastatin—Nausea—Etoposide—brain cancer	0.000118	0.00124	CcSEcCtD
Lovastatin—ABCB1—endocrine gland—brain cancer	0.000114	0.00241	CbGeAlD
Lovastatin—CYP2D6—brain—brain cancer	0.000113	0.00239	CbGeAlD
Lovastatin—ABCB1—head—brain cancer	0.000112	0.00238	CbGeAlD
Lovastatin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00105	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00103	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—PIK3CG—brain cancer	0.000105	0.00103	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—STAT3—brain cancer	0.000104	0.00101	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—BSG—brain cancer	0.000104	0.00101	CbGpPWpGaD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—brain cancer	0.000104	0.00101	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—IRS2—brain cancer	0.000103	0.001	CbGpPWpGaD
Lovastatin—ABCB1—central nervous system—brain cancer	0.000102	0.00217	CbGeAlD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000102	0.00099	CbGpPWpGaD
Lovastatin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000101	0.000982	CbGpPWpGaD
Lovastatin—ABCB1—cerebellum—brain cancer	0.0001	0.00212	CbGeAlD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL2—brain cancer	9.77e-05	0.000952	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	9.71e-05	0.000946	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—MYC—brain cancer	9.68e-05	0.000943	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	9.63e-05	0.000938	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	9.62e-05	0.000937	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.59e-05	0.000934	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—SIRT1—brain cancer	9.52e-05	0.000927	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—CDKN2A—brain cancer	9.47e-05	0.000922	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.45e-05	0.000921	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—STAT3—brain cancer	9.33e-05	0.000909	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—APC—brain cancer	9.05e-05	0.000881	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—TP53—brain cancer	9.01e-05	0.000878	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—MYC—brain cancer	8.87e-05	0.000864	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.82e-05	0.000859	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	8.77e-05	0.000854	CbGpPWpGaD
Lovastatin—HDAC2—Disease—DTX2—brain cancer	8.75e-05	0.000852	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	8.74e-05	0.000851	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—VAV1—brain cancer	8.7e-05	0.000847	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.7e-05	0.000847	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—EGFR—brain cancer	8.68e-05	0.000845	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—brain cancer	8.57e-05	0.000835	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.39e-05	0.000818	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.36e-05	0.000814	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	8.24e-05	0.000802	CbGpPWpGaD
Lovastatin—ABCB1—brain—brain cancer	8.14e-05	0.00172	CbGeAlD
Lovastatin—HDAC2—Signaling by NGF—VAV1—brain cancer	8.05e-05	0.000784	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—CTNNB1—brain cancer	7.98e-05	0.000778	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	7.79e-05	0.000759	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	7.71e-05	0.000751	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—CCND1—brain cancer	7.58e-05	0.000739	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IL2—brain cancer	7.41e-05	0.000722	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	7.31e-05	0.000712	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	7.24e-05	0.000705	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—OR4C12—brain cancer	7.21e-05	0.000702	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—OR14C36—brain cancer	7.21e-05	0.000702	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—CDK4—brain cancer	7.2e-05	0.000701	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.18e-05	0.000699	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PDGFRA—brain cancer	7.12e-05	0.000694	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—RELA—brain cancer	7.12e-05	0.000693	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—ERBB2—brain cancer	7.07e-05	0.000689	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TRPC6—brain cancer	6.81e-05	0.000663	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—CDK4—brain cancer	6.77e-05	0.000659	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PDGFRA—brain cancer	6.59e-05	0.000642	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—MYC—brain cancer	6.47e-05	0.00063	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HES5—brain cancer	6.42e-05	0.000626	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	6.37e-05	0.000621	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—VEGFA—brain cancer	6.3e-05	0.000614	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—TP53—brain cancer	6.27e-05	0.000611	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IRS2—brain cancer	6.25e-05	0.000609	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CYP2C9—brain cancer	6.19e-05	0.000603	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.14e-05	0.000598	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DTX2—brain cancer	6.13e-05	0.000597	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—MYC—brain cancer	6.08e-05	0.000593	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.96e-05	0.000581	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	5.86e-05	0.000571	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IRS2—brain cancer	5.79e-05	0.000564	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.76e-05	0.000562	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	5.73e-05	0.000559	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.69e-05	0.000554	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TP53—brain cancer	5.27e-05	0.000513	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—BSG—brain cancer	5.27e-05	0.000513	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.25e-05	0.000511	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VAV1—brain cancer	5.1e-05	0.000497	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP2C9—brain cancer	5.05e-05	0.000492	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—brain cancer	5e-05	0.000487	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.97e-05	0.000484	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—EGFR—brain cancer	4.9e-05	0.000477	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—EGFR—brain cancer	4.87e-05	0.000474	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	4.82e-05	0.000469	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TP53—brain cancer	4.76e-05	0.000464	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.71e-05	0.000459	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTCH2—brain cancer	4.64e-05	0.000452	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—IDH1—brain cancer	4.53e-05	0.000441	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HES5—brain cancer	4.5e-05	0.000438	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.45e-05	0.000433	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—CCND1—brain cancer	4.37e-05	0.000426	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STRADA—brain cancer	4.37e-05	0.000425	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IDH1—brain cancer	4.32e-05	0.000421	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—RELA—brain cancer	4.32e-05	0.00042	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP2C9—brain cancer	4.29e-05	0.000418	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—BSG—brain cancer	4.29e-05	0.000418	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ERBB2—brain cancer	4.29e-05	0.000418	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—brain cancer	4.19e-05	0.000408	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.12e-05	0.000402	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.12e-05	0.000402	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HEY1—brain cancer	4.1e-05	0.000399	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—brain cancer	4.09e-05	0.000398	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.05e-05	0.000394	CbGpPWpGaD
Lovastatin—HDAC2—Disease—DLL1—brain cancer	4.02e-05	0.000391	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—RELA—brain cancer	3.99e-05	0.000389	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.98e-05	0.000388	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—ERBB2—brain cancer	3.97e-05	0.000387	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL2—brain cancer	3.89e-05	0.000379	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.8e-05	0.00037	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CTNNB1—brain cancer	3.75e-05	0.000365	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP2C9—brain cancer	3.74e-05	0.000364	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.73e-05	0.000363	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—IDH1—brain cancer	3.69e-05	0.00036	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.69e-05	0.000359	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.68e-05	0.000359	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—BSG—brain cancer	3.65e-05	0.000356	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ABR—brain cancer	3.64e-05	0.000355	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ENO2—brain cancer	3.58e-05	0.000349	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GLI2—brain cancer	3.52e-05	0.000343	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP2C9—brain cancer	3.49e-05	0.00034	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SHH—brain cancer	3.42e-05	0.000333	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ENO2—brain cancer	3.42e-05	0.000333	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GLI1—brain cancer	3.31e-05	0.000322	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—DNMT1—brain cancer	3.28e-05	0.000319	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—STAT3—brain cancer	3.27e-05	0.000319	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.27e-05	0.000318	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2—brain cancer	3.25e-05	0.000317	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PIK3CG—brain cancer	3.24e-05	0.000315	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.2e-05	0.000312	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	3.2e-05	0.000311	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.19e-05	0.000311	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—BSG—brain cancer	3.18e-05	0.00031	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.16e-05	0.000308	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—IDH1—brain cancer	3.14e-05	0.000306	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SUFU—brain cancer	3.14e-05	0.000306	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—brain cancer	3.06e-05	0.000298	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GFAP—brain cancer	3.03e-05	0.000295	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—STAT3—brain cancer	3.03e-05	0.000295	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.02e-05	0.000294	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—brain cancer	2.97e-05	0.00029	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—BSG—brain cancer	2.97e-05	0.000289	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ESR2—brain cancer	2.94e-05	0.000287	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.94e-05	0.000287	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP2C9—brain cancer	2.93e-05	0.000286	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ENO2—brain cancer	2.92e-05	0.000284	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HEY1—brain cancer	2.87e-05	0.000279	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DLL1—brain cancer	2.81e-05	0.000274	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.8e-05	0.000273	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NOTCH2—brain cancer	2.79e-05	0.000272	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.76e-05	0.000269	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—brain cancer	2.75e-05	0.000268	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—IDH1—brain cancer	2.73e-05	0.000266	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—BSG—brain cancer	2.72e-05	0.000265	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.69e-05	0.000262	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—IDH1—brain cancer	2.55e-05	0.000248	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—BSG—brain cancer	2.49e-05	0.000243	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ENO2—brain cancer	2.48e-05	0.000242	CbGpPWpGaD
Lovastatin—HDAC2—Disease—VAV1—brain cancer	2.47e-05	0.00024	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.45e-05	0.000239	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.42e-05	0.000236	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SHH—brain cancer	2.39e-05	0.000233	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SIRT1—brain cancer	2.37e-05	0.000231	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—IDH1—brain cancer	2.34e-05	0.000228	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TRPC6—brain cancer	2.31e-05	0.000225	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.28e-05	0.000222	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—brain cancer	2.28e-05	0.000222	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SMO—brain cancer	2.27e-05	0.000221	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTCH1—brain cancer	2.27e-05	0.000221	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.23e-05	0.000217	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ENO2—brain cancer	2.16e-05	0.00021	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—IDH1—brain cancer	2.14e-05	0.000209	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HES1—brain cancer	2.12e-05	0.000207	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP2C9—brain cancer	2.12e-05	0.000207	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PDGFRA—brain cancer	2.02e-05	0.000197	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ENO2—brain cancer	2.02e-05	0.000196	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—brain cancer	1.94e-05	0.000189	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.9e-05	0.000185	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.9e-05	0.000185	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ENO2—brain cancer	1.85e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000179	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOTCH2—brain cancer	1.81e-05	0.000177	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BSG—brain cancer	1.8e-05	0.000176	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IRS2—brain cancer	1.77e-05	0.000173	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.77e-05	0.000173	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VAV1—brain cancer	1.73e-05	0.000168	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ENO2—brain cancer	1.7e-05	0.000165	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.64e-05	0.00016	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP2C9—brain cancer	1.64e-05	0.00016	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000156	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APC—brain cancer	1.57e-05	0.000153	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.57e-05	0.000152	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BSG—brain cancer	1.56e-05	0.000152	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—IDH1—brain cancer	1.55e-05	0.000151	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.55e-05	0.000151	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000147	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HES1—brain cancer	1.49e-05	0.000145	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—brain cancer	1.46e-05	0.000143	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PDGFRA—brain cancer	1.42e-05	0.000138	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BSG—brain cancer	1.39e-05	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPP1—brain cancer	1.37e-05	0.000134	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.36e-05	0.000133	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BSG—brain cancer	1.36e-05	0.000133	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—IDH1—brain cancer	1.34e-05	0.000131	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CG—brain cancer	1.34e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BSG—brain cancer	1.28e-05	0.000125	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BSG—brain cancer	1.27e-05	0.000124	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.26e-05	0.000122	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IRS2—brain cancer	1.24e-05	0.000121	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.23e-05	0.00012	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ENO2—brain cancer	1.23e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB2—brain cancer	1.22e-05	0.000119	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—IDH1—brain cancer	1.2e-05	0.000117	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—IDH1—brain cancer	1.17e-05	0.000114	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000111	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—IDH1—brain cancer	1.1e-05	0.000107	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APC—brain cancer	1.1e-05	0.000107	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CG—brain cancer	1.1e-05	0.000107	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.09e-05	0.000107	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—IDH1—brain cancer	1.09e-05	0.000106	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—brain cancer	1.06e-05	0.000104	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ENO2—brain cancer	1.06e-05	0.000103	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.03e-05	0.0001	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CG—brain cancer	9.91e-06	9.65e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2C9—brain cancer	9.86e-06	9.6e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.76e-06	9.51e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ENO2—brain cancer	9.48e-06	9.23e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—brain cancer	9.29e-06	9.05e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—brain cancer	9.28e-06	9.04e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CG—brain cancer	9.25e-06	9.01e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ENO2—brain cancer	9.25e-06	9.01e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.9e-06	8.67e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ENO2—brain cancer	8.72e-06	8.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ENO2—brain cancer	8.64e-06	8.42e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—brain cancer	8.62e-06	8.4e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RELA—brain cancer	8.58e-06	8.35e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—brain cancer	8.52e-06	8.3e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	8.47e-06	8.25e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—brain cancer	8.44e-06	8.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BSG—brain cancer	8.38e-06	8.16e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—brain cancer	7.78e-06	7.58e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—brain cancer	7.72e-06	7.52e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—brain cancer	7.53e-06	7.33e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—brain cancer	7.46e-06	7.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH1—brain cancer	7.21e-06	7.02e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—brain cancer	6.56e-06	6.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—brain cancer	6.5e-06	6.33e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—brain cancer	6.04e-06	5.88e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—brain cancer	5.91e-06	5.75e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO2—brain cancer	5.7e-06	5.55e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—brain cancer	5.62e-06	5.48e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—brain cancer	4.96e-06	4.83e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—brain cancer	4.87e-06	4.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—brain cancer	4.35e-06	4.23e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—brain cancer	4.24e-06	4.13e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—brain cancer	4e-06	3.89e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	3.96e-06	3.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.61e-06	2.55e-05	CbGpPWpGaD
